Reversing the trend of short-term reversal

Disclaimer Robeco Switzerland Ltd.

The information contained on these pages is solely for marketing purposes.

Access to the funds is restricted to (i) Qualified Investors within the meaning of art. 10 para. 3 et sequ. of the Swiss Federal Act on Collective Investment Schemes (“CISA”), (ii) Institutional Investors within the meaning of art. 4 para. 3 and 4 of the Financial Services Act (“FinSA”) domiciled Switzerland and (iii) Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.

The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Leutschenbachstrasse 50, CH-8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent.

The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website https://www.robeco.com/ch.

Some funds about which information is shown on these pages may fall outside the scope of CISA and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).

Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the Robeco Switzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.

Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as prospectuses, annual and semi-annual reports.

By clicking “I agree” you confirm that you/the company you represent falls under one of the above-mentioned categories of addressees and that you have read, understood and accept the terms of use for this website.

Reversing the trend of short-term reversal

Has the short-term reversal effect truly vanished? In a new paper, Robeco's Quant Investing research team—Chief Researcher David Blitz, and Senior Researchers Bart van der Grient and Iman Honarvar—continue to explore the complex landscape of short-term reversal strategies. Serving as a sequel to the 2022 publication, "Beyond Fama-French Factors: Alpha from Short-Term Signals," this latest paper addresses growing concerns about the short-term reversal phenomenon.

Read the full paper

The team reveals that the strategy can be revived by counteracting its conflicting tendencies with short-term industry and factor momentum. Enhanced reversal strategies offer double the risk-adjusted return and remain effective over time.

The authors also infer that the premium for this strategy likely originates from temporary supply-demand imbalances, positioning investors as liquidity providers, thereby enhancing market efficiency. The insights garnered from this research are incorporated in Robeco's recently introduced Quantum short-term alpha strategy. For an in-depth look at unlocking the secrets of short-term reversal strategies, read the full paper here: Reversing the trend of short-term reversals on SSRN.

Read the full paper